Expert Review of Pharmacoeconomics & Outcomes Research
Taylor and Francis Ltd. · England
Metrics
- Impact factor
- 2.2+0.7 Clarivate JCR
- WoS quartile
- Q3 Clarivate JCR, best category
- SJR
- 0.511Q3 SCImago
- h-index
- 41
- CAS tier
- Tier 4 Chinese Academy of Sciences
- Citations per paper
- 2.19 last 2 years
- Articles per year
- 118
- Self-citation
- 11.1%
- Fee (APC), est.
- $3,014 estimated, check the journal
About this journal
- ISSN
- 1473-7167 (print) · 1744-8379 (online)
- Publisher
- Taylor and Francis Ltd. · Taylor & Francis
- Country
- England · Western Europe
- Indexed in
- SCIE, SSCI
- Access
- Hybrid · 11.6% gold OA
- Original research
- 82.7%
- Subject areas
- Medicine
- Categories
- Health Care Sciences & Services, Pharmacology & Pharmacy
- Common topics
- Medicine, Biology, Economics, Internal medicine, Pathology
Similar journals
- Q3WoS
Brain Research
Impact factor 3.2h-index 188SJR 0.89 - Q3WoS
Current Protocols
Impact factor 2.5h-index 157SJR 1.04 - Q3WoS
International Journal of Systematic and Evolutionary Microbiology
Impact factor 2.3h-index 156SJR 0.63 - Q3WoS
Memory & Cognition
Impact factor 1.8h-index 152SJR 1.08 - Q3WoS
Review of Scientific Instruments
Impact factor 1.6h-index 145SJR 0.42 - Q3WoS
Journal of the Optical Society of America A-Optics Image Science and Vision
Impact factor 1.5h-index 144SJR 0.41
Figures as of the last import; ranks are a guide, not a verdict. Back to all journals